Published in Am Heart J on July 01, 1985
Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. N Engl J Med (1999) 6.93
Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients. GUSTO-I Investigators. Circulation (1995) 3.38
Thrombolysis with tissue plasminogen activator in acute myocardial infarction: no additional benefit from immediate percutaneous coronary angioplasty. Lancet (1988) 2.90
Current spectrum of cardiogenic shock and effect of early revascularization on mortality. Results of an International Registry. SHOCK Registry Investigators. Circulation (1995) 2.07
Digital necrosis associated with chronic myeloid leukemia: a rare paraneoplastic phenomenon. Acta Clin Belg (1995) 1.95
Thrombolysis in patients with unstable angina improves the angiographic but not the clinical outcome. Results of UNASEM, a multicenter, randomized, placebo-controlled, clinical trial with anistreplase. Circulation (1992) 1.73
Lack of progress in cardiogenic shock: lessons from the GUSTO trials. Eur Heart J (2000) 1.50
Coronary artery reperfusion in acute myocardial infarction: assessment by pre- and postintervention thallium-201 myocardial perfusion imaging. Am J Cardiol (1985) 1.47
Safety of low-molecular-weight heparin in pregnancy: a systematic review. Thromb Haemost (1999) 1.31
Activated partial thromboplastin time and outcome after thrombolytic therapy for acute myocardial infarction: results from the GUSTO-I trial. Circulation (1996) 1.16
SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK: an international randomized trial of emergency PTCA/CABG-trial design. The SHOCK Trial Study Group. Am Heart J (1999) 1.15
Cardiogenic shock due to cardiac free-wall rupture or tamponade after acute myocardial infarction: a report from the SHOCK Trial Registry. Should we emergently revascularize occluded coronaries for cardiogenic shock? J Am Coll Cardiol (2000) 1.09
Cardiac tamponade early after thrombolysis for acute myocardial infarction: a rare but not reported hemorrhagic complication. J Am Coll Cardiol (1991) 1.07
Early discharge in the thrombolytic era: an analysis of criteria for uncomplicated infarction from the Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO) trial. J Am Coll Cardiol (1996) 1.07
A new hematologic syndrome with a distinct karyotype: the 5 q--chromosome. Blood (1975) 1.05
Liver transplantation and haemophilia A. J Hepatol (1995) 0.94
Human ABO-incompatible living donor renal homografts. Neth J Med (1985) 0.92
Meningococcal purpura: report of 19 patients treated with heparin. J Pediatr (1973) 0.89
Hydropneumopericardium with tamponade as a late complication of surgical repair of hiatus hernia. Am Heart J (1987) 0.89
Ibopamine in very severe congestive heart failure: pilot haemodynamic invasive assessment. Eur J Clin Pharmacol (1983) 0.88
Hepatic sickling: an unusual cause of liver allograft dysfunction. Transplantation (1999) 0.84
PaCO(2)/ETCO(2) gradient: early indicator of thrombolysis efficacy in a massive pulmonary embolism. Resuscitation (2001) 0.84
Myocardial protection by intracoronary nicardipine administration during percutaneous transluminal coronary angioplasty. Am J Cardiol (1987) 0.83
Cardiac troponin I as an early marker of myocardial damage after coronary bypass surgery. Eur J Cardiothorac Surg (1998) 0.83
Effects of suloctidil on platelet survival time following cardiac valve replacement. Thromb Haemost (1981) 0.81
Amrinone in the management of low cardiac output after open heart surgery. Am J Cardiol (1985) 0.80
Clinical and biological activity of the antiplatelet agent suloctidil in treatment of idiopathic recurrent vein thrombosis (I.R.V.T.). Thromb Haemost (1982) 0.80
Haemostasis disorders in open heart surgery with extracorporeal circulation. Importance of the platelet function and the heparin neutralization. Vox Sang (1977) 0.79
[Emergency surgery for massive hemorrhage from ruptured esophageal varices in the cirrhotic patient (author's transl)]. Acta Gastroenterol Belg (1974) 0.79
Angioplasty of coronary bifurcation stenoses: immediate and long-term results of the protecting branch technique. Cathet Cardiovasc Diagn (1991) 0.79
Comparative effects of dextrans, gelatin and stable plasma protein solution (SPPS) on the experimental disseminated intravascular coagulation (DIC). Vox Sang (1974) 0.79
Isolation of the left coronary artery ostium by an aortic cusp attachment: a rare cause of myocardial ischemia. Eur J Cardiothorac Surg (1994) 0.79
Hemostasis variables in type I diabetic patients without demonstrable vascular complications. Diabetes Care (1993) 0.78
Treatment of severe verapamil poisoning with combined amrinone-isoproterenol therapy. Am J Cardiol (1986) 0.78
Cardiogenic shock with non-ST-segment elevation myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded coronaries for Cardiogenic shocK? J Am Coll Cardiol (2000) 0.77
Effects of pimobendan (UD-CG 115 BS) on left ventricular inotropic state in conscious dogs and in patients with heart failure. J Cardiovasc Pharmacol (1989) 0.77
Platelet anti-aggregant and rheological properties of piracetam. A pharmacodynamic study in normal subjects. Arzneimittelforschung (1993) 0.76
Hydroxyethylrutosides in elderly patients with chronic venous insufficiency: its efficacy and tolerability. Gerontology (1994) 0.76
Viability of long-term cryopreserved human saphenous veins. J Cardiovasc Surg (Torino) (1990) 0.76
Acquired activated protein C resistance in pregnancy. Thromb Res (1996) 0.76
Living-related and unrelated donor kidney transplantation: comparison between ABO-compatible and incompatible grafts. Transplant Proc (1987) 0.76
Effects of alpha and beta receptor stimulating and blocking agents on experimental disseminated intravascular coagulation. Thromb Diath Haemorrh (1974) 0.76
Heparin and antifibrinolytic agents during experimental hepatectomy and liver transplantation. Pathol Eur (1969) 0.76
Hemostasis in children undergoing liver transplantation. Semin Thromb Hemost (1993) 0.75
Prevalence of activated protein C resistance and analysis of clinical profile in thromboembolic patients. A Belgian prospective study. J Intern Med (1997) 0.75
Acute haemodynamic effects of ibopamine in patients with severe congestive heart failure. Br J Clin Pharmacol (1985) 0.75
[Functional somatic complaints in the emergency service and 4 year outcome]. Schweiz Arch Neurol Psychiatr (1994) 0.75
The lupus anticoagulant. Ann Ital Med Int (1986) 0.75
The prothrombin gene G20210A variant in an unselected thromboembolic population. A Belgian prospective clinical study. Acta Clin Belg (1998) 0.75
Scintigraphy with Indium-labelled leukocytes in acute pancreatitis. Acta Gastroenterol Belg (1992) 0.75
Successful orthotopic transplantation of the canine liver after prolonged preservation by initial perfusion and cold storage. Eur Surg Res (1973) 0.75
[Hematological problems in cardiovascular diseases]. Rev Med Liege (1979) 0.75
Two-level non-invasive positive pressure ventilation in the initial treatment of acute respiratory failure in an emergency department. Eur J Emerg Med (1999) 0.75
[Preservation of the liver with a view to transplantation. II. Orthotopic transplantation of the liver after perfusion]. Rev Int Hepatol (1965) 0.75
[Treatment of the first episode of pulmonary embolism in the hospital. Anticoagulants, anti-platelet aggregation drugs and thrombolysis stimulants]. Acta Chir Belg (1986) 0.75
[Blood platelet survival and arterial thrombosis]. Acta Clin Belg (1977) 0.75
[Evaluation of tolerance of a modified protein diet in obese subjects]. Diabete Metab (1983) 0.75
Have the platelet antiheparin and antiplasmin activities the same support? Thromb Diath Haemorrh (1969) 0.75
Iterative cardiac catheterization: usefulness and limitations in follow-up studies. Adv Cardiol (1986) 0.75
[A case of Moschcowitz syndrome associated with a Rickettsia mooseri infection]. Nouv Rev Fr Hematol (1973) 0.75
[Surgical plasty of the left main coronary artery]. Ann Chir (1989) 0.75
[Disorders of hemostasis and blood coagulation during uremia. 3. Role of platelet anomalies and action of hemodialysis and renal grafts]. Pathol Eur (1966) 0.75
Detection of restenosis after successful coronary angioplasty: improved clinical decision making with use of a logistic model combining procedural and follow-up variables. J Am Coll Cardiol (1990) 0.75
Case 5--1996. Thrombosis after the use of a heparin-coated cardiopulmonary bypass circuit in a patient with heparin-induced thrombocytopenia. J Cardiothorac Vasc Anesth (1996) 0.75
Proceedings: Critical analysis of platelet factor 4 (antiheparin activity) assays. Thromb Diath Haemorrh (1975) 0.75
[Natural inhibitors of fibrinolysis and thrombohemorrhagic phenomena]. Pathol Eur (1969) 0.75
[Hemostasis disorders in patients with multiple injuries]. Cah Anesthesiol (1972) 0.75
Effect of intracoronary thrombolytic therapy on exercise-induced ischemia after acute myocardial infarction. Am J Cardiol (1985) 0.75
[Disorders of hemostasis and blood coagulation in uremia. I. Clinical study]. Rev Belg Pathol Med Exp (1965) 0.75
Non-heart-beating donor, 10-year experience in a Belgian transplant center. Transplant Proc (2007) 0.75
[Disorders of hemostasis and blood coagulation in uremia. II. Experimental study]. Rev Belg Pathol Med Exp (1965) 0.75
[Surgical revascularization for angina decubitus following myocardial infarction]. Ann Chir (1985) 0.75
Belgian standards for factor VIII related properties: preliminary data. Acta Clin Belg (1982) 0.75
Treatment of the Raynaud's phenomenon with piracetam. Arzneimittelforschung (1993) 0.75
Modifications of liver enzymes during heparin therapy. Acta Clin Belg (1986) 0.75
BWGIC guidelines for training and quality control in adult interventional cardiology. Belgian Working Group of Invasive Cardiology. Acta Cardiol (1997) 0.75
[Pulmonary embolectomy. Clinical experience]. Acta Chir Belg (1986) 0.75
[Vitamin K antagonists and platelet aggregation inhibitors in the prevention of thrombosis]. Acta Clin Belg (1977) 0.75
[1st results of a systematic survey of cancer in different Belgian populations]. Arch Belg Med Soc (1967) 0.75
[Diagnosis and treatment of intravascular coagulation processes]. Nouv Rev Fr Hematol (1968) 0.75
A novel preservation medium protecting prostacyclin production and endothelial integrity of the human saphenous vein graft. Thromb Res Suppl (1990) 0.75
Effect of the variation of hematocrit on the proteinuria of a patient with polycythemia and congenital heart disease. Nephron (1987) 0.75
[Chest pain and electrocardiographic changes in the presence of stenosis of the left common coronary artery]. Acta Clin Belg (1995) 0.75
Emergencies and somatization. Acta Clin Belg (1996) 0.75
Acute cardiogenic pulmonary edema and pregnancy: a ten-year experience. Intensive Care Med (1988) 0.75
[Hemodynamics and massive pulmonary embolism]. Acta Chir Belg (1986) 0.75
Percutaneous transluminal coronary angioplasty of the left coronary artery in patients with chronic occlusion of the right coronary artery: clinical and functional results. Am Heart J (1991) 0.75
Comparative effects of proteinase inhibitors, plasminogen antiactivators, heparin and acetylsalicylic acid on the experimental disseminated intravascular coagulation induced by thormbin. Thromb Diath Haemorrh (1974) 0.75
The treatment of severe or recurrent deep venous thrombosis. Beneficial effect of the co-administration of antiplatelet agents with or without rheological effects, and anticoagulants. Thromb Res (1995) 0.75
[Prognosis and treatment of bacterial endocarditis. Review of 70 cases]. Acta Cardiol (1975) 0.75
Measurement of platelet regeneration time in cardiovascular patients. Thromb Res (1979) 0.75
Experience with early quadruple immunosuppressive therapy in heart transplantation. Bibl Cardiol (1988) 0.75
Orthotopic heart transplantation eleven years after left pneumonectomy. J Heart Transplant (1988) 0.75